Listen Ad-free

Piece of Mind: Mental Health & Psychiatry

Piece of Mind: Mental Health & Psychiatry

We bring you the latest on mental health research at the National Centre for Mental Health (NCMH) and the Centre for Neuropsychiatric Genetics and Genomics at Cardiff University, plus real-life experiences of people affected by mental health problems.


We would love to hear your feedback or ideas for future episodes, either comment on our latest episode, message us at info@ncmh.info or include #POMpod in our social media posts.


Hosted on Acast. See acast.com/privacy for more information.

read less
Health & FitnessHealth & Fitness

Episodes

Episode 13: Learning disability, autism, and support into work
Apr 26 2024
Episode 13: Learning disability, autism, and support into work
In this episode of the Piece of Mind podcast, we're joined by Andrea Meek, Dr Elisa Vigna, and Gerraint Jones-Griffiths to discuss the Engage to Change project which has supported over 1,200 young people with a learning disability or autism into employment over the last eight years.Engage to Change has worked across Wales since 2016 to support young people aged 16-25 who have a learning difficulty, learning disability, or autism to achieve their full potential. The project has worked with over 1,200 young people to offer job placements, supported internships, and job coach support over a seven year period.Engage to Change is now in its 'Influencing and Informing' phase, taking forward the research and legacy work of the project to ensure it impacts policy and practise in Wales. The project is funded by the Lottery Community Fund in partnership with Welsh Government.To learn more about the Engage to Change project, visit: https://www.engagetochange.org.uk/Links mentioned in this video:Engage to Change: https://www.engagetochange.org.uk/research-evaluation/NCMH blog: https://www.ncmh.info/2023/05/22/getting-young-people-with-autism-and-learning-disabilities-into-employment-ncmh-finds-out-what-works/Project highlights video: https://youtu.be/pjwKKGmKaGAJob coach support video: https://www.youtube.com/watch?v=LTdwF4FIFvEInterviews with family video: https://www.youtube.com/watch?v=gXmwQx8RdO8 Hosted on Acast. See acast.com/privacy for more information.
Episode 11: PMDD - the hidden link between hormones and mental health
Jan 16 2024
Episode 11: PMDD - the hidden link between hormones and mental health
In this episode of the Piece of Mind podcast, we're joined by Becci Smart and Chloe Apsey to discuss the reality of living with Premenstrual Dysphoric Disorder (PMDD) and the research currently taking place at the NCMH that's looking to learn more to improve diagnosis and treatment.PMDD is a mood disorder that is estimated to affect around 5% of women and people who have periods. That’s around 80,000 people in the UK. During the week before the onset of bleeding (known as the luteal phase of the menstrual cycle), these people with PMDD experience severe mood and emotional changes including anxiety and low mood, a decreased interest in their usual activities, difficulties concentrating and more. These symptoms improve within a few days after menstrual bleeding (the period). To be diagnosed with PMDD, these symptoms need to be associated with extreme distress and interfere with ‘everyday’ functioning.   To learn more about the NCMH PreDDICT study looking into PMDD, visit https://www.ncmh.info/pmdd Tools and organisations mentioned in this episodeIAPMD: https://iapmd.org/Self-screening tool: https://iapmd.org/self-screenSymptom tracking tool: https://iapmd.org/symptom-trackerWhen referring to the experiences of women throughout this episode and within our research we acknowledge the experiences of AFAB (assigned female at birth) and non-binary individuals and encourage their participation in our research. Further guidance can be found at: https://iapmd.org/transgender-pmdd Hosted on Acast. See acast.com/privacy for more information.
Minisode: Clozapine, neutropenia and treatment-resistant schizophrenia
Feb 27 2019
Minisode: Clozapine, neutropenia and treatment-resistant schizophrenia
We’re delighted to be joined by Dr Sophie Legge and Dr Antonio Pardiñas for our latest minisode to discuss their latest research study.Sophie, Antonio and colleagues at Cardiff University’s MRC Centre for Neuropsychiatric Genetics and Genomics examined genetic data from more than 500 people of African descent taking clozapine, an anti-psychotic medication prescribed to people with treatment resistant schizophrenia.Clozapine is currently the most effective treatment for people with treatment-resistant schizophrenia, but it can cause a rare side effect called neutropenia. In the most extreme cases, this can develop into agranulocytosis; a severe and potentially life-threatening condition.These side-effects are characterised by lower neutrophil levels, a type of white blood cell, and these lower levels appear to be more common in people of African descent. The team were interested in learning whether genetic factors were at play, and in this minisode Sophie and Antonio explain what they found and how their results could help improve the management of clozapine treatment.For links and resources mentioned in this episode, visit https://www.ncmh.info/podcastWe hope you enjoy and we would be really grateful if you could leave us a review and help others find our podcast! If you've got any questions about this episode, get in touch at info@ncmh.info. Hosted on Acast. See acast.com/privacy for more information.